BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26474311)

  • 1. Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis.
    Maria AT; Toupet K; Bony C; Pirot N; Vozenin MC; Petit B; Roger P; Batteux F; Le Quellec A; Jorgensen C; Noël D; Guilpain P
    Arthritis Rheumatol; 2016 Apr; 68(4):1013-25. PubMed ID: 26474311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis.
    Maria AT; Toupet K; Maumus M; Fonteneau G; Le Quellec A; Jorgensen C; Guilpain P; Noël D
    J Autoimmun; 2016 Jun; 70():31-9. PubMed ID: 27052182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells.
    Maria ATJ; Toupet K; Maumus M; Rozier P; Vozenin MC; Le Quellec A; Jorgensen C; Noël D; Guilpain P
    Front Immunol; 2018; 9():2571. PubMed ID: 30455706
    [No Abstract]   [Full Text] [Related]  

  • 4. iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis.
    Maria ATJ; Rozier P; Fonteneau G; Sutra T; Maumus M; Toupet K; Cristol JP; Jorgensen C; Guilpain P; Noël D
    Front Immunol; 2018; 9():3056. PubMed ID: 30622540
    [No Abstract]   [Full Text] [Related]  

  • 5. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
    Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F
    Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
    Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
    Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
    Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
    Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
    Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
    J Immunol; 2016 Oct; 197(8):3018-3028. PubMed ID: 27613696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
    Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.
    Mendoza FA; Piera-Velazquez S; Farber JL; Feghali-Bostwick C; Jiménez SA
    Arthritis Rheumatol; 2016 Jan; 68(1):210-7. PubMed ID: 26360820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.
    Servettaz A; Kavian N; Nicco C; Deveaux V; Chéreau C; Wang A; Zimmer A; Lotersztajn S; Weill B; Batteux F
    Am J Pathol; 2010 Jul; 177(1):187-96. PubMed ID: 20508030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
    Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
    Front Immunol; 2019; 10():1861. PubMed ID: 31481954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The organotelluride catalyst (PHTE)₂NQ prevents HOCl-induced systemic sclerosis in mouse.
    Marut WK; Kavian N; Servettaz A; Nicco C; Ba LA; Doering M; Chéreau C; Jacob C; Weill B; Batteux F
    J Invest Dermatol; 2012 Apr; 132(4):1125-32. PubMed ID: 22277946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular superoxide dismutase increased the therapeutic potential of human mesenchymal stromal cells in radiation pulmonary fibrosis.
    Wei L; Zhang J; Yang ZL; You H
    Cytotherapy; 2017 May; 19(5):586-602. PubMed ID: 28314668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.
    Bagnato G; Bitto A; Irrera N; Pizzino G; Sangari D; Cinquegrani M; Roberts W; Atteritano M; Altavilla D; Squadrito F; Bagnato G; Saitta A
    Arthritis Res Ther; 2013 Sep; 15(5):R120. PubMed ID: 24286160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
    Servettaz A; Goulvestre C; Kavian N; Nicco C; Guilpain P; Chéreau C; Vuiblet V; Guillevin L; Mouthon L; Weill B; Batteux F
    J Immunol; 2009 May; 182(9):5855-64. PubMed ID: 19380834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung Fibrosis Is Improved by Extracellular Vesicles from IFNγ-Primed Mesenchymal Stromal Cells in Murine Systemic Sclerosis.
    Rozier P; Maumus M; Maria ATJ; Toupet K; Jorgensen C; Guilpain P; Noël D
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.